The possible benefits from early initiation and long-term treatment of liraglutide
10.3760/cma.j.issn.1000-6699.2014.12.023
- VernacularTitle:利拉鲁肽早期启用和长期治疗的可能获益
- Author:
Tianpei HONG
- Publication Type:Journal Article
- Keywords:
Liraglutide;
Glucagon-like peptide-1;
Diabetes mellitus,type 2;
β cell function
- From:
Chinese Journal of Endocrinology and Metabolism
2014;30(12):1144-1147
- CountryChina
- Language:Chinese
-
Abstract:
Early intervention and preservation of β-cell function are essential for optimal glycemic control in the long term.Available data support the early use of the long-acting glucagon-like peptide-1 analogue liraglutide in preservation of β-cell mass and function,leading to better glycemic control.Besides glycemic control,persistent weight loss and reduced visceral adiposity are observed in type 2 diabetic patients treated with liraglutide,linking to its potential cardio-protective effects.
